Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy H Newman

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|September 21, 2007
Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuseShariq A Syed, Amy H Newman, Ahmed A Othman, et al.
Behavioural Pharmacology|October 8, 2011
Drinking sucrose enhances quinpirole-induced yawning in ratsMichelle G Baladi, Amy H Newman, Yvonne M Thomas, et al.
Psychopharmacology|June 11, 2009
The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeysCindy Achat-Mendes, Donna M Platt, Amy H Newman, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuseAhmed A Othman, Shariq A Syed, Amy H Newman, et al.
Frontiers in Behavioral Neuroscience|January 30, 2020
Dopamine D<sub>3</sub> Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock RatsGiordano de Guglielmo, Marsida Kallupi, Sharona Sedighim, et al.
Psychopharmacology|October 21, 2014
Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigmWilliam S John, Ashwini K Banala, Amy H Newman, et al.
Psychopharmacology|September 15, 2012
The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administrationLibin Li, Takato Hiranita, Shuichiro Hayashi, et al.
Addiction Biology|May 12, 2010
The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-accessLaura Orio, Sunmee Wee, Amy H Newman, et al.
Behavioural Pharmacology|June 23, 2011
Effects of selective dopaminergic compounds on a delay-discounting taskMikhail N Koffarnus, Amy H Newman, Peter Grundt, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2005
Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogsRajeev I Desai, Theresa A Kopajtic, Dawn French, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|September 21, 2007
Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuseShariq A Syed, Amy H Newman, Ahmed A Othman, et al.
Behavioural Pharmacology|October 8, 2011
Drinking sucrose enhances quinpirole-induced yawning in ratsMichelle G Baladi, Amy H Newman, Yvonne M Thomas, et al.
Psychopharmacology|June 11, 2009
The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeysCindy Achat-Mendes, Donna M Platt, Amy H Newman, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuseAhmed A Othman, Shariq A Syed, Amy H Newman, et al.
Frontiers in Behavioral Neuroscience|January 30, 2020
Dopamine D<sub>3</sub> Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock RatsGiordano de Guglielmo, Marsida Kallupi, Sharona Sedighim, et al.
Psychopharmacology|October 21, 2014
Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigmWilliam S John, Ashwini K Banala, Amy H Newman, et al.
Psychopharmacology|September 15, 2012
The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administrationLibin Li, Takato Hiranita, Shuichiro Hayashi, et al.
Addiction Biology|May 12, 2010
The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-accessLaura Orio, Sunmee Wee, Amy H Newman, et al.
Behavioural Pharmacology|June 23, 2011
Effects of selective dopaminergic compounds on a delay-discounting taskMikhail N Koffarnus, Amy H Newman, Peter Grundt, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2005
Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogsRajeev I Desai, Theresa A Kopajtic, Dawn French, et al.
Pageof 8